Live Breaking News & Updates on President Stephen Hoge|Page 4

Stay updated with breaking news from President stephen hoge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Swiss National Bank Decreases Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)

Swiss National Bank trimmed its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 2.9% during the fourth quarter, Holdings Channel reports. The fund owned 1,011,600 shares of the company’s stock after selling 30,700 shares during the period. Swiss National Bank’s holdings in Moderna were worth $100,604,000 as of its most recent filing with the […] ....

United States , William Blair , Stephen Hoge , Noubar Afeyan , Stratos Wealth Advisors , Holdings Channel , Moderna Company Profile , Brown Advisory Inc , Canaccord Genuity Group , Needham Company , Moderna Inc , Securities Exchange Commission , Mackenzie Financial Corp , Royal Bank , Raymond James Associates , Swiss National Bank , Free Report , National Bank , Wealth Advisors , Financial Corp , Director Noubar Afeyan , President Stephen Hoge , Genuity Group , Get Free Report , Visit Holdingschannel , Moderna Daily ,

Moderna (NASDAQ:MRNA) PT Raised to $135.00 at Royal Bank of Canada

Moderna (NASDAQ:MRNA – Get Free Report) had its price target raised by analysts at Royal Bank of Canada from $125.00 to $135.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s price target indicates a potential upside of 8.00% from the […] ....

United States , William Blair , Ogorek Anthony Joseph , Stephen Hoge , Canaccord Genuity Group , Moderna Inc , Royal Bank , Arlington Trust Co , Rise Advisors , Westside Investment Management Inc , Securities Exchange Commission , Needham Company , Get Free Report , President Stephen Hoge , Exchange Commission , Shannon Thyme Klinger , Anthony Joseph , Investment Management , Moderna Daily , Nasdaq Mrna , Boost Price Target , Royal Bank Of Canada ,

Moderna (NASDAQ:MRNA) Stock Price Up 9.4% Following Better-Than-Expected Earnings

Moderna, Inc. (NASDAQ:MRNA – Get Free Report) was up 9.4% during trading on Thursday following a stronger than expected earnings report. The company traded as high as $122.81 and last traded at $121.99. Approximately 5,955,355 shares changed hands during mid-day trading, an increase of 46% from the average daily volume of 4,065,655 shares. The stock […] ....

United States , William Blair , Noubar Afeyan , Stephen Hoge , National Association , Canaccord Genuity Group , Moderna Inc , Needham Company , Eversource Wealth Advisors , Principle Wealth Partners , Securities Exchange Commission , Income Strategies , Royal Bank , Get Free Report , President Stephen Hoge , Exchange Commission , Director Noubar Afeyan , Wealth Partners , Source Wealth Advisors , Stock Down , Moderna Daily , Nasdaq Mrna ,

Moderna (NASDAQ:MRNA) Price Target Increased to $163.00 by Analysts at Oppenheimer

Moderna (NASDAQ:MRNA – Get Free Report) had its price objective increased by equities researchers at Oppenheimer from $142.00 to $163.00 in a report released on Friday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s target price suggests a potential upside of 30.50% from the stock’s current price. MRNA has been […] ....

United States , Ogorek Anthony Joseph , Noubar Afeyan , Stephen Hoge , William Blair , Rise Advisors , Arlington Trust Co , Jefferies Financial Group , Westside Investment Management Inc , Securities Exchange Commission , Royal Bank , Moderna Company Profile , Moderna Inc , Canaccord Genuity Group , Needham Company , Get Free Report , Financial Group , Director Noubar Afeyan , Exchange Commission , President Stephen Hoge , Anthony Joseph , Investment Management , Moderna Daily ,

Moderna (MRNA) Scheduled to Post Quarterly Earnings on Thursday

Moderna (NASDAQ:MRNA – Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Thursday, May 2nd. Analysts expect Moderna to post earnings of ($3.36) per share for the quarter. Moderna has set its FY 2024 guidance at EPS.Parties that wish to register for the company’s conference call can do […] ....

United States , Noubar Afeyan , Stephen Hoge , William Blair , Securities Exchange Commission , Moderna Inc , Canaccord Genuity Group , Royal Bank , Get Free Report , Genuity Group , President Stephen Hoge , Director Noubar Afeyan , Exchange Commission , Moderna Daily , Nasdaq Mrna ,